Showing results (881-890 of 936) with videos related to

Sort By:
Pageof 94
The Lancet. Oncology|May 7, 2025
Standard versus reduced-dose chemoradiotherapy in anal cancer (PLATO-ACT4): short-term results of a phase 2 randomised controlled trialAlexandra Gilbert, Richard Adams, Joanne Webster, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 25, 2011
Phase Ia clinical evaluation of the Plasmodium falciparum blood-stage antigen MSP1 in ChAd63 and MVA vaccine vectorsSusanne H Sheehy, Christopher J A Duncan, Sean C Elias, et al.
Wellcome Open Research|April 13, 2026
Phase I/IIa study to assess the safety, immunogenicity and efficacy of ChAdOx1-MVA vectored vaccines expressing a novel liver-stage malaria dual antigen LS2 by sporozoite challenge in malaria-naïve adultsDaniel Silman, Amy Flaxman, Mehreen Datoo, et al.
Nature Communications|June 24, 2018
Rational Zika vaccine design via the modulation of antigen membrane anchors in chimpanzee adenoviral vectorsCésar López-Camacho, Peter Abbink, Rafael A Larocca, et al.
The Lancet. Oncology|April 30, 2026
On-treatment serum prostate-specific antigen and overall survival in prostate cancer (STAMPEDE platform protocol): a post-hoc analysis of data from five phase 3 trialsMahaz Kayani, Laura Murphy, Peter Dutey-Magni, et al.
Plos One|February 25, 2012
Phase Ia clinical evaluation of the safety and immunogenicity of the Plasmodium falciparum blood-stage antigen AMA1 in ChAd63 and MVA vaccine vectorsSusanne H Sheehy, Christopher J A Duncan, Sean C Elias, et al.
The Journal of Infectious Diseases|November 9, 2018
Safety and Immunogenicity of a Heterologous Prime-Boost Ebola Virus Vaccine Regimen in Healthy Adults in the United Kingdom and SenegalNavin Venkatraman, Birahim Pierre Ndiaye, Georgina Bowyer, et al.
Infection and Immunity|December 12, 2007
Characterization of the fine specificity of bovine CD8 T-cell responses to defined antigens from the protozoan parasite Theileria parvaSimon P Graham, Roger Pellé, Mat Yamage, et al.
The Journal of Infectious Diseases|January 26, 2012
Clinical assessment of a recombinant simian adenovirus ChAd63: a potent new vaccine vectorGeraldine A O'Hara, Christopher J A Duncan, Katie J Ewer, et al.
Contemporary Clinical Trials|March 27, 2024
Getting our ducks in a row: The need for data utility comparisons of healthcare systems data for clinical trialsMatthew R Sydes, Macey L Murray, Saiam Ahmed, et al.
Pageof 94